Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Organised by the Nuffield Department of Population Health, University of Oxford 11th November 2019 at Merton College, Merton Street Oxford, 9:30 am to 5:00 pm

A symposium to mark the 60th anniversary of the Hinchliffe Report - a Government Committee tasked with examining the rise in pharmaceutical expenditure following the introduction of the NHS.     

      Its recommendations were far-reaching including:    

  • Improvements in the training of GPs to understand evidence regarding the use of new drugs and the economics of prescribing;      
  • Routinely conducting clinical trials to assess drugs and to publish results in an independent prescribers’ journal;      
  • Development of an expert body that would be informed by research on economic and social aspects of the NHS;      
  • An examination of the economics of drug development, marketing and pharmacy to ensure efficiency and equity in prescribing;      

The purpose of the workshop is firstly to reflect on the report in order to understand the degree to which we face similar challenges today, and the degree to which we have been able to address these challenges. Secondly, if a Government was to commission a report to look at pharmaceutical expenditure today, what potential long-term recommendations could be made to address current challenges.


Registration fees: (please note: early bird closes on 20 September)

Early bird Corporate/Industry - £200
Early bird Academic/Public Sector - £100

Corporate/Industry - £250
Academic/Public Sector - £125
Higher Degree Student - £55 

Following the conference is a drinks reception between 5-6pm.  Please indicate on the questionnaire whether you will be in attendance.


Confirmed speakers include    

  • Dr Amanda Adler, Chair of NICE Appraisal Committee and Consultant Physician        
  • Prof Philip Clarke, Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford        
  • Prof Sir Rory Collins, Prof Louise Bowman, Clinical Trials at the Clinical Trial Service Unit, Nuffield Department of Population Health, University of Oxford        
  • Sir Andrew Dillon, CEO, National Institute for Health and Care Excellence        
  • Dr Elaine Kelly, Senior Research Economist, Institute of Fiscal Studies and the Health Foundation        
  • Prof Martin Landray, Big Data Institute, Nuffield Department of Population Health, University of Oxford        
  • Mr Danny Palnoch, Head of Medicines Analysis, Strategy and Policy, NHS England        
  • Prof Adrian Towse, Office of Health Economics